期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血管性血友病因子研究进展 被引量：3

原文传递
导出
摘要 血管性血友病因子在止血和血栓形成过程中发挥重要作用,并与心、脑血管疾病及血管新生密切相关。研究血管性血友病因子的结构和功能,将为血管性血友病及其他相关疾病的诊断和治疗提供可靠理论基础。
作者 张媛 郭智 何学鹏 陈惠仁
机构地区 北京军区总医院血液科
出处 《中华实用诊断与治疗杂志》 2010年第11期1045-1047,共3页 Journal of Chinese Practical Diagnosis and Therapy
关键词 血管性血友病 血管性血友病因子 血栓性疾病
分类号 R554.1 [医药卫生—血液循环系统疾病]
  • 相关文献

参考文献23

  • 1Andrews R K, Berndt M C. Platelet physiology and thrombosis [J]. Thromb Res,2004,114(5-6) :447- 453.
  • 2Mancuso D J, Tuley E A, Westt'ield L A, et al. Human yon Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction [J]. Biochemistry, 1991,30(1):253- 269.
  • 3Mannucci P M. von Willebrand factor: a prima ballerina on two different stages[J]. Semin Hematol, 2005,42 ( 1 ) : 1-4.
  • 4Katsumi A, Tuley E A, Bodo I, et al. Localization of disulfide bonds in the cystine knot domain of human von Willebrand factor [J]. J BiolChem,2000,275(33):25585-25594.
  • 5Borchiellini A, Fijnvandraat K, ten Care J W, et al. Quantitative analysis of yon Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1 deamino-8-D-arginine vasopressin in humans[J]. Blood, 1996, 88(8) :2951- 2958.
  • 6Chng W J, Yip C Y, Baliwag M B, et al. Differential effect of the ABO blood group on yon Willebrand factor collagen binding activity and ristocetin cofactor assay [J]. Blood Coagul FibrJnolysis,2005 ,16(1) :75~78.
  • 7Sadler J E, Moake J L, Miyata T, et al. Recent advances in thrombotic thrombocytopenic purpura[J]. Hematology Am Soe Hematol Educ Program,2004:407-423.
  • 8Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of yon Willebrand's disease[J]. Blood,1987,69(2) :454- 459.
  • 9Sadler J E, Mannucci P M, Berntorp E, etal. Impact, diagnosis and treatment of yon Willebrand disease[J]. Thromb Haemost, 2000,84(2) :160-174.
  • 10Goodeve A, Eikenboom J, Castaman G, et al. Phenotype and genotype of a cohort of families historicaily diagnosed with type 1 yon Willebrand disease in the European study. Molecular and Clinical Markers for the Diagnosis and Management of Type 1 yon Willebrand Disease (MCMDM-IVWD) [J]. Blood, 2007, 109(1):112-121.

二级参考文献30

  • 1曹国良,乔永芳,刘新兵,俞建华.辛伐他汀早期干预对非ST抬高型急性冠脉综合征细胞因子水平的影响[J].实用诊断与治疗杂志,2006,20(7):478-480. 被引量：40
  • 2无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量：2072
  • 3梁皓,赵文增.重要炎症因子与冠心病的关系[J].实用诊断与治疗杂志,2007,21(5):364-366. 被引量：27
  • 4柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量：2146
  • 5Biasucci L M, Liuzzo G, Grillo R L, et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability[J].Circulation, 1999, 99(7):855-860.
  • 6Antman E M, Anbe D T, Armstrong P W, et al. ACC/AHA guideline for the management of patients with ST-elevation myocardial infarction; A report of American College of Cardiology/American Heart Association task force on practice guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infartion)[J]. J AM Coil Cardial, 2004,44 (3) : E211.
  • 7Gensini G G. A more meaningful scoring system for determining the severityof coronary heart disease[J].Am J Cardiol,1983,51 (3) :606.
  • 8Shah P K. Mechanisms of plaque vulnerability and rupture[J].J Am Coll Cardial,2003,41(4 Suppl S) :15s-22s.
  • 9Sano T, Tanaka A, Namba M, et al. Patients C reactive protein and lension morphology infarction in with acute myoeardial[J]. Circulation, 2003,108 ( 3 ) : 282-285.
  • 10Hans Erik Botker, Ingerslev J. Attenuation of hypothermia-induced platelet activation and platelet adhesion to artificial surfaces in vitro by modification of hemoglobin to carry S-nitric oxide and polyethylene glycol[J].Thromb Res, 2000,100 ( 6 ) : 519-528.

共引文献24

同被引文献17

引证文献3

二级引证文献3

中华实用诊断与治疗杂志
2010年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部